MiR-126 reinstatement combined with MMP inhibition blocked HB-EGF expression in colonic tissues and suppressed tumor formation in a CRC tumor model and the AOM DSS colon carcinogenesis model. This evidence concerns the gene HBEGF and colorectal carcinoma.